The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes
Open accessAbstract
Fibroblast growth factor 21 (FGF21) has beneficial effects of improving the plasma glucose and lipid profiles in diabetic rodents. Here, we investigated carbohydrate response element binding protein (ChREBP) involvement in the regulation of FGF21 mRNA expression in liver. Glucose stimulation and adenoviral overexpression of dominant active ChREBP increased FGF21 mRNA. Consistently, adenoviral expression of dominant negative Mlx inhibited glucose induction of FGF21 mRNA. Furthermore, deletion studies of mouse FGF21 gene promoter (−2000 to +65 bp) revealed a glucose responsive region between −74 and −52 bp. These findings suggest that FGF21 expression is regulated by ChREBP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatic mRNA and plasma protein levels of FGF21 are induced by high sugar intake through a mechanism dependent on the transcription factor ChREBP22–25”
From Metabolic messengers: FGF21 (2021) · cites this paper as [23]
In the citing paper
“An intermediate in this pathway, xylulose-5-phosphate, activates ChREBP (1) and promotes its binding to the carbohydrate response element sites in the promoters of target genes, including FGF21 (53, 130).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [53]
In the citing paper
“The stimulation of FGF21 production by carbohydrates is mediated by the transcription factor carbohydrate-response element-binding protein (ChREBP).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [53]
In the citing paper
“Circulating FGF21 levels are robustly increased by diets that are high in carbohydrate but low in protein”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [137]
In the citing paper
“liver FGF21 production seems to be robustly stimulated by an imbalance in macronutrients, particularly settings of high-carbohydrate but low-protein intake”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [137]
In the citing paper
“Both acute carbohydrate ingestion and long-term exposure to high-carbohydrate diets significantly increase liver FGF21 mRNA expression and circulating FGF21 levels”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [137]
In the citing paper
“driven at least in part by the transcription factor carbohydrate response element binding protein (ChREBP), which binds directly to the FGF21 promoter”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [137]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A. (2008) · Endocrinology · doi:10.1210/en.2008-0816 · Cited by 1,031
Zhang, X., Yeung, D. C. Y., Karpisek, M., Stejskal, D., Zhou, Z.-G., Liu, F., Wong, R. L. C., Chow, W.-S., Tso, A. W. K., Lam, K. S. L., et al. (2008) · Diabetes · doi:10.2337/db07-1476 · Cited by 908
Identification of a novel FGF, FGF-21, preferentially expressed in the liver
Nishimura, T., Nakatake, Y., Konishi, M., & Itoh, N. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00067-1 · Cited by 847
Iizuka, K., Bruick, R. K., Liang, G., Horton, J. D., & Uyeda, K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401516101 · Cited by 834
Self-citationKurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704165200 · Cited by 748
Wente, W., Efanov, A. M., Brenner, M. B., Kharitonenkov, A., Koster, A. M., Sandusky, G. E., Sewing, S., Treinies, I., Zitzer, H., & Gromada, J. (2006) · Diabetes · doi:10.2337/db05-1435 · Cited by 497
FGF21 is an Akt‐regulated myokine
Izumiya, Y., Bina, H. A., Ouchi, N., Akasaki, Y., Kharitonenkov, A., & Walsh, K. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.10.021 · Cited by 415
Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21
Inagaki, T., Lin, V. Y., Goetz, R., Mohammadi, M., Mangelsdorf, D. J., & Kliewer, S. A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.05.006 · Cited by 409
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–187 of 187
Suzuki, T., Muramatsu, T., Morioka, K., Goda, T., & Mochizuki, K. (2015) · Nutrition · doi:10.1016/j.nut.2015.01.005 · Cited by 29
ChREBP Rather Than SHP Regulates Hepatic VLDL Secretion
Niwa, H., Iizuka, K., Kato, T., Wu, W., Tsuchida, H., Takao, K., Horikawa, Y., & Takeda, J. (2018) · Nutrients · doi:10.3390/nu10030321 · Cited by 27
Self-citationBurke, S. J., Batdorf, H. M., Martin, T. M., Burk, D. H., Noland, R. C., Cooley, C. R., Karlstad, M. D., Johnson, W. D., & Collier, J. J. (2018) · Obesity · doi:10.1002/oby.22217 · Cited by 29
Fibroblast growth factor 21 and autophagy: A complex interplay in Parkinson disease
Kakoty, V., Sarathlal, K. C., Tang, R.-D., Yang, C. H., Dubey, S. K., & Taliyan, R. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110145 · Cited by 27
Effect of circulating glucagon and free fatty acids on hepatic FGF21 production in dairy cows
Caixeta, L. S., Giesy, S. L., Krumm, C. S., Perfield, J. W., Butterfield, A. M., Schoenberg, K. M., Beitz, D. C., & Boisclair, Y. R. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00197.2017 · Cited by 29
Iizuka, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112058 · Cited by 36
Self-citationFibroblast Growth Factor 21 Facilitates the Homeostatic Control of Feeding Behavior
Wu, C.-T., CHAFFIN, A. T. B., & Ryan, K. K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030580 · Cited by 24
Endocrine Fibroblast Growth Factors in Relation to Stress Signaling
Shimizu, M., & Sato, R. (2022) · Cells · doi:10.3390/cells11030505 · Cited by 25
Pérez‐Martí, A., Sandoval, V., Marrero, P. F., Haro, D., & Relat, J. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0034 · Cited by 24
Vienberg, S. G., Jacobsen, S. H., Worm, D., Hvolris, L., Naver, L., Almdal, T., Hansen, D. L., Wulff, B. S., Clausen, T. R., Madsbad, S., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.13241 · Cited by 24
Xiang, C., Zhang, Y., Chen, Q., Sun, A., Peng, Y., Zhang, G., Zhou, D., Xie, Y., Hou, X., Zheng, F., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16698 · Cited by 23
Flightless I homolog negatively regulates ChREBP activity in cancer cells
Wu, L., Chen, H., Zhu, Y., Meng, J., Li, Y., Li, M., Yang, D., Zhang, P., Feng, M., & Tong, X. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.09.004 · Cited by 23
Song, Z., Yang, H., Zhou, L., & Yang, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205132 · Cited by 22
Kim, G.-Y., Lee, Y., Cho, J., Pan, C., Jun, H. S., Springer, D., Mansfield, B. C., & CHOU, J. Y. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv230 · Cited by 21
Liver-directed gene therapy for murine glycogen storage disease type Ib
Kwon, J. H., Lee, Y., Cho, J., Kim, G., Anduaga, J., Starost, M. F., Mansfield, B. C., & CHOU, J. Y. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx325 · Cited by 22
Relationship between FGF21 and drug or nondrug therapy of type 2 diabetes mellitus
Guo, C. Y., Zhao, L., Li, Y., Deng, X., & Yuan, G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29879 · Cited by 21
Imamura, W., Yoshimura, R., Takai, M., Yamamura, J., Kanamoto, R., & Kato, H. (2013) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.59.45 · Cited by 20
ChREBP and LXRα mediate synergistically lipogenesis induced by glucose in porcine adipocytes
Zhang, G. H., Lu, J. X., Chen, Y., Guo, P. H., Qiao, Z. L., Feng, R., Chen, S. E., Bai, J. L., Huo, S. D., & Ren, Z. (2015) · Gene · doi:10.1016/j.gene.2015.03.057 · Cited by 19
Endoplasmic reticulum stress at the forefront of fatty liver diseases and cancer
Karin, M., & Kim, J. Y. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100096 · Cited by 20
Causative and Sanative dynamicity of ChREBP in Hepato-Metabolic disorders
Daniel, P. V., & Mondal, P. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151128 · Cited by 18
Postprandial dynamics and response of fibroblast growth factor 21 in older adults
Herpich, C., Haß, U., Kochlik, B., Franz, K., Laeger, T., Klaus, S., Bosy‐Westphal, A., & Norman, K. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.04.037 · Cited by 17
Men, L., Hui, W., Guan, X., Song, T., Wang, X., Zhang, S., & Chen, X. (2020) · Genes · doi:10.3390/genes11070720 · Cited by 16
Cheung, C. Y. Y., Tang, C. S.-M., Xu, A., Lee, C., Au, K., Xu, L., Fong, C. H.-Y., Kwok, K. H. M., Chow, W.-S., Woo, Y. C., et al. (2017) · Diabetes · doi:10.2337/db16-1384 · Cited by 16
The Function of MondoA and ChREBP Nutrient—Sensing Factors in Metabolic Disease
Ahn, B. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108811 · Cited by 16
Neuronal Mechanisms that Drive Organismal Aging Through the Lens of Perception
Gendron, C. M., Chakraborty, T. S., Chung, B. Y., Harvanek, Z. M., Holme, K. J., Johnson, J. C., Lyu, Y., Munneke, A. S., & Pletcher, S. D. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034440 · Cited by 17
The Role of Mondo Family Transcription Factors in Nutrient-Sensing and Obesity
Ke, H., Luan, Y., Wu, S., Zhu, Y., & Tong, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.653972 · Cited by 14
Iizuka, K., Tomita, R., Takeda, J., & Horikawa, Y. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.042 · Cited by 15
Self-citationMonar, G. V. F., Cruz, C. S., & Martinez, E. C. (2025) · Journal of Nutrition and Metabolism · doi:10.1155/jnme/5571686 · Cited by 14
Roles of Ca2+ ions in the control of ChREBP nuclear translocation
Leclerc, I., Rutter, G. A., Meur, G., & Noordeen, N. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0480 · Cited by 15
Špolcová, A., Holubová, M., Mikulášková, B., Nagelová, V., Štofková, A., Lacinová, Z., Jur̀čovičová, J., Haluzı́k, M., Maletı́nská, L., & Železná, B. (2014) · Physiological Research · doi:10.33549/physiolres.932714 · Cited by 13
Jois, T., & Sleeman, M. W. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12473 · Cited by 14
Advances in Oral Biomacromolecule Therapies for Metabolic Diseases
Jiao, Q., Huang, Y., He, J., & Xu, Y. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020238 · Cited by 13
Richter, M. M., Thomsen, M. N., Skytte, M. J., Kjeldsen, S. A. S., Samkani, A., Frystyk, J., Magkos, F., Holst, J. J., Madsbad, S., Krarup, T., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae008 · Cited by 13
Kim, S. Q., Spann, R. A., Khan, M. S. H., Berthoud, H., Münzberg, H., Albaugh, V. L., He, Y., McDougal, D. H., Soto, P. L., Yu, S., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110010 · Cited by 10
Characterization of FGF21 Sites of Production and Signaling in Mice
Sullivan, A. I., Jensen-Cody, S. O., Claflin, K. E., Vorhies, K., Flippo, K. H., & Potthoff, M. J. (2024) · Endocrinology · doi:10.1210/endocr/bqae120 · Cited by 11
Cheong, M. C., Mackowiak, B., Kim, H. B., Hernandez, G., Nandu, T. S., Vale, K., Zhang, Y., Zacharias, L. G., Mathews, T. P., Gao, B., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2505263122 · Cited by 11
Qian, Z., Zhang, Y., Yang, N., Nie, H., Yang, Z. L., Luo, P., Wei, X., Guan, Y., Huang, Y., Yan, J., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.984828 · Cited by 11
Soleimani-Dodran, M., Alipanah-Moghadam, R., Jeddi, F., Babaei, M., Salimnejad, R., & Bahreini, E. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00699-9 · Cited by 11
Fructose Metabolism and Its Effect on Glucose-Galactose Malabsorption Patients: A Literature Review
Alruwaili, N. W., & Alshdayed, F. (2023) · Diagnostics · doi:10.3390/diagnostics13020294 · Cited by 13
Metformin Improves the Prerequisites for FGF21 Signaling in Patients With Type 2 Diabetes
Pedersen, A. K. N., Gormsen, L. C., Nielsen, S., Jessen, N., & Bjerre, M. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad583 · Cited by 10
Wei, X., Jia, R., Yang, Z., Jiang, J., Huang, J., Yan, J., & Luo, X. M. (2020) · FEBS Letters · doi:10.1002/1873-3468.13779 · Cited by 10
Samms, R. J., Cheng, C., Fourcaudot, M. J., Heikkinen, S., Khattab, A., Adams, J. M., Cersósimo, E., Triplitt, C. L., PUCKETT, C. L., Tsintzas, K., et al. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00050.2022 · Cited by 10
New insights into the inter-organ crosstalk mediated by ChREBP
Carbinatti, T., Régnier, M., Parlati, L., Benhamed, F., & Postic, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1095440 · Cited by 13
Th2 Cytokines Increase the Expression of Fibroblast Growth Factor 21 in the Liver
Kang, S., Lee, S. E., Choi, M., Chang, J.-Y., Kim, J.-T., Zhang, B., Kang, Y.-E., Lee, J. H., Yi, H., & Shong, M. (2021) · Cells · doi:10.3390/cells10061298 · Cited by 9
Yamada, Y., Saito, H., Araki, M., Tsuchimoto, Y., Muroi, S.-I., Kyohei, S., Toume, K., Kim, J., Matsuzaka, T., Sone, H., et al. (2022) · Nutrients · doi:10.3390/nu14193920 · Cited by 9
Lunati, M. E., Bedeschi, M. F., Resi, V., Grancini, V., Palmieri, E., Salera, S., Lalatta, F., Pugliese, G., & Orsi, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185371 · Cited by 10
Glucose-dependent GPER1 expression modulates tamoxifen-induced IGFBP-1 accumulation
Zheng, Y., & Houston, K. D. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0253 · Cited by 9
Sex Differences in Ketogenic Diet Response Reveal Gonadal Hormone Interaction With FGF21 in Mice
Zhang, Y., Cochran, J. D., Souvenir, R., Tai, W. C., Xia, R., Gladwin, B. S., Barton, N. B., Pereira, R. O., & Abel, E. D. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf131 · Cited by 8
Zhang, Y., Wang, T., Han, J., Song, J., Yang, C., Liang, L., Li, H., & Wang, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1610498 · Cited by 9
The Regulation of Circulating Hepatokines by Fructose Ingestion in Humans
Richter, M. M., & Plomgaard, P. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab121 · Cited by 7
Girer, N. G., Rontoyanni, V. G., Joshi, A., Patrikeev, I., Murton, A. J., Porter, C. C., Motamedi, M., & Elferink, C. J. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000514 · Cited by 7
Neurosecretory Protein GL Promotes Normotopic Fat Accumulation in Male ICR Mice
Narimatsu, Y., Matsuura, D., Ukena, K., Furumitsu, M., & Ukena, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126488 · Cited by 7
Kiani, B., Yarahmadi, S., Nabi‐Afjadi, M., Eskandari, H., Hasani, M., Abbasian, Z., & Bahreini, E. (2022) · Clinical Diabetology · doi:10.5603/dk.a2022.0051 · Cited by 6
Gehring, J., Azzout‐Marniche, D., Chaumontet, C., Piedcoq, J., Gaudichon, C., & Even, P. C. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00246.2021 · Cited by 7
Olivares, S., & Henkel, A. S. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.09.006 · Cited by 6
Nielsen, M. S., Søberg, S., Schmidt, J. B., Chenchar, A., Sjödin, A. M., & Gillum, M. P. (2021) · PeerJ · doi:10.7717/peerj.11174 · Cited by 5
FOXO1 represses PPARα-Mediated induction of FGF21 gene expression
Sousa‐Coelho, A. L. D., Gacias, M., O'Neill, B. T., Relat, J., Link, W., Haro, D., & Marrero, P. F. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.01.012 · Cited by 5
Doridot, L., Hannou, S. A., Krawczyk, S. A., Tong, W., Kim, M.-S., McElroy, G. S., Fowler, A. J., Astapova, I. I., & Herman, M. A. (2021) · Nutrients · doi:10.3390/nu13103642 · Cited by 5
UPRmt-regulated mitokines: novel strategies for myocardial injury repair
Gao, W., Liu, J., Zhang, W., Liu, B., & Shen, L. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1652353 · Cited by 4
Szczepańska, E., Glinicki, P., Zgliczyński, W., Slowinska-Srzednicka, J., Jastrzębska, H., & Gietka‐Czernel, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.900034 · Cited by 3
Liver, but Not Muscle, Has an Entrainable Metabolic Memory
Chen, S., Otero, Y. F., Mulligan, K. X., Lundblad, T. M., Williams, P. E., & McGuinness, O. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086164 · Cited by 3
Nutritional Intake and the Risk for Non-alcoholic Fatty Liver Disease (NAFLD)
Bergheim, I., & Schattenberg, J. M. (2019) · MDPI eBooks · doi:10.3390/books978-3-03897-599-1 · Cited by 4
Role of ChREBP–PPARα–FGF21 Axis in Metabolic Dysfunction of MASLD
Girón, K. M. P., Nazará, Z., Maldonado‐González, M., Martínez‐López, E., Sánchez-Muñoz, M. P., Bautista-López, C. A., Aldana-Aguiñaga, M. S., Domínguez-Rosales, J. A., Vargas‐Guerrero, B., & Ruiz‐Madrigal, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311425 · Cited by 3
Ghosh, C., Arora, V., Barman, J., Chatterjee, S., Hazra, S., Sircar, D., Kumar, P., & Roy, P. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107168 · Cited by 2
Pohlhammer, J., Heinzl, M. W., Klammer, C., Feldbauer, R., Rosenberger, K., Resl, M., Wagner, T., Obendorf, F., Egger-Salmhofer, M., Dieplinger, B., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17614 · Cited by 1
Efendi, O. G. H. N. B., Matsui, S., Tsukamoto, M., Oguri, Y., Tsuzuki, S., & Sasaki, T. (2025) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbaf147 · Cited by 1
ChREBP-mediated regulation of lipid metabolism in liver and brown adipose tissue of long-lived mice
Hager, M., Adam, C., Mercier, L., Voorhees, A., Lee, M., Ball, L., Yang, J., Bartke, A., Miller, R. A., & Li, X. (2026) · GeroScience · doi:10.1007/s11357-026-02263-2 · Cited by 1
Fujihara, Y., Kodo, Y., Miyoshi, S.-I., Watanabe, R., Toyoda, H., Mankura, M., Kabuto, H., & Takayama, F. (2021) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.20-201 · Cited by 1
Prezotto, L. D., Keane, J. A., Cupp, A. S., & Thorson, J. F. (2023) · Animals · doi:10.3390/ani13203185 · Cited by 1
Nelson, B. T. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Thompson, A. C. S. (2014) · ProQuest Demo Repository
Prevalencia de hipotiroidismo en una población dislipidémica mayor de 35 años de Manizales, Colombia
Osório, J. H., & Aguirre, C. A. (2016) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v64n4.53220
The Sweet Path to Metabolic Demise: Fructose and Lipid
Herman, S. A., & Samuel, V. T. (2016)
Mehmood, R. (2011) · doi:10.3998/panc.2011.35
Signaling pathway and pharmacology
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00005-6
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00000-7
Schmidt, H. M., Tarling, E. J., & Vallim, T. Q. D. A. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2512733122
Chen, Z., Xu, M., Chen, S., & Chen, L. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110977
Mondo family proteins in diabetes
Barodia, S. K., Grant, M. B., & Gorbatyuk, M. S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1745162
Osthole Activates FGF21 Expression by Mediating Activation of ATF4 in Human Hepatocyte HepG2 Cells
Taguchi, A., Araki, M., Yamashita, T., Kanazawa, R., Terao, I., Suzuki, K., Tsuchimoto, Y., Matsuzaka, T., Sone, H., Shimano, H., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021003
Inter-organ communication in physiology and pathophysiology : a role for the ChREBP-FGF21 axis?
Carbinatti, T. (2024) · theses.fr (ABES) · doi:10.70675/5d147ab4zad37z4f6bzac51z32a08efeaa51
FGF21-inducing rare sugars for addressing obesity and alcoholism
Sasaki, T. (2026) · The Journal of Biochemistry · doi:10.1093/jb/mvag059
Metadata
- Authors
- Iizuka, K., Takeda, J., & Horikawa, Y.
- Affiliations
- Gunma University (JP)
- Gifu University (JP)
- Corresponding author
- Horikawa, Yukio
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2009-08-04
- Volume
- 583
- Issue
- 17
- Pages
- 2882-2886
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2075349430
- Cited by
- 187
- References
- 25
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 6 · 2023: 9 · 2022: 15 · 2021: 22 · 2020: 8 · 2019: 16 · 2018: 12 · 2017: 18 · 2016: 20 · 2015: 13 · 2014: 7 · 2013: 6 · 2012: 10
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- FEBS Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science
- New Energy and Industrial Technology Development Organization
- Health and Labor Science Research Grant for Research on Human Genome
- Japanese Ministry of Health, Labor and Welfare
- ONO Medical Research Foundation
- Kao Research Council for the Study of Healthcare Science
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- FGF21, ChREBP, glucose, hepatocytes, MLX, transcriptional regulation
- MeSH terms
- Animals, Cells, Cultured, Fibroblast Growth Factors, Glucose, Promoter Regions, Genetic, RNA, Messenger, Transcriptional Activation, Trans-Activators, Hepatocytes, Mice, Rats, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
